Barbara Coco

5.0k citations

99 papers · 4.0k · 2 hit papers · h-index 27

Impact in

Hepatology top 0.2%
- Hepatitis C virus research
- Liver Diseases and Immunity
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis Viruses Studies and Epidemiology
Epidemiology top 1%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies

Papers in

Hepatology 67
- Hepatitis C virus research 50
- Liver Diseases and Immunity 15
- Hepatitis Viruses Studies and Epidemiology 4
- Hepatocellular Carcinoma Treatment and Prognosis 3
Epidemiology 57
- Hepatitis B Virus Studies 40
- Liver Disease Diagnosis and Treatment 35

Co-authors: Maurizia Rossana Brunetto (45 shared papers)Ferruccio Bonino (34 shared papers)Filippo Oliveri (28 shared papers)Piero Colombatto (30 shared papers)Pietro Ciccorossi (14 shared papers)Rodolfo Sacco (6 shared papers)A.M. Maina (2 shared papers)Veronica Romagnoli (14 shared papers)
Journals: Digestive and Liver Disease (24 papers)Journal of Hepatology (20 papers)Gastroenterology (5 papers)Alimentary Pharmacology & Therapeutics (3 papers)Liver International (3 papers)
Partner nations: Italy United States China

In The Last Decade

Barbara Coco

93 papers receiving 3.9k citations

Barbara Coco's Hit Papers

align trajectories log scale

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study 2022 · 479 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2022 The Lancet. Gastroenterology & hepatology
2006 Journal of Viral Hepatitis

Peers

Countries citing papers authored by Barbara Coco

Since Specialization

Citations

This map shows the geographic impact of Barbara Coco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Coco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Coco more than expected).

Fields of papers citing papers by Barbara Coco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Coco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Coco. The network helps show where Barbara Coco may publish in the future.

Co-authors

The 25 scholars most cited alongside Barbara Coco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Coco Line = papers co-authored together Barbara Coco links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases Journal of Viral Hepatitis ·Barbara Coco, Filippo Oliveri, A.M. Maina, Pietro Ciccorossi, Rodolfo Sacco, Piero Colombatto, Ferruccio Bonino, Maurizia Rossana Brunetto Hit paper breakdown →	2006	587
2	Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study The Lancet. Gastroenterology & hepatology ·Sarah Blach, Norah A. Terrault, Frank Tacke, Ivane Gamkrelidze, Antonio Craxı̀, Junko Tanaka, Imam A. Waked, Gregory J. Dore Hit paper breakdown →	2022	479
3	Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis Nature Genetics ·Xiangdong Liu, Pietro Invernizzi, Yue Lu, Roman Kosoy, Yan Lü, Ilaria Bianchi, Mauro Podda, Chun Xu	2010	345
4	Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers Gastroenterology ·Maurizia Rossana Brunetto, Filippo Oliveri, Piero Colombatto, Francesco Moriconi, Pietro Ciccorossi, Barbara Coco, Veronica Romagnoli, Beatrice Cherubini	2010	330
5	Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study Journal of Hepatology ·Maurizia Rossana Brunetto, Filippo Oliveri, Barbara Coco, Gioacchino Leandro, Piero Colombatto, Juliana Monti Gorin, Ferruccio Bonino	2002	285
6	International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways Nature Communications ·Heather Jane Cordell, Younghun Han, George F. Mells, Yafang Li, Gideon Morris Hirschfield, Casey S. Greene, Gang Xie, Brian D. Juran	2015	220
7	Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma Digestive and Liver Disease ·Luigi Bolondi, Umberto Cillo, Massimo G. Colombo, Antonio Craxı̀, Fabio Farinati, Edoardo Giovanni Giannini, Rita Golfieri, Massimo Levrero	2013	158
8	TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues Gastroenterology ·Carolina Boni, Andrea Lorenzo Vecchi, Marzia Rossi, Diletta Laccabue, Tiziana Giuberti, Arianna Alfieri, Pietro Lampertico, Glenda Grossi	2018	123
9	Liver stiffness in the hepatitis B virus carrier: A non-invasive marker of liver disease influenced by the pattern of transaminases World Journal of Gastroenterology ·Filippo Oliveri, Barbara Coco, Pietro Ciccorossi, Piero Colombatto, Veronica Romagnoli, Beatrice Cherubini, Ferruccio Bonino, Maurizia Rossana Brunetto	2008	120
10	Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis Gastroenterology ·Carolina Boni, Harry L.A. Janssen, Marzia Rossi, Seung Kew Yoon, Andrea Lorenzo Vecchi, Valeria Barili, Eric M. Yoshida, Huy Ngoc Trinh	2019	113
11	An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs Journal of Hepatology ·Heather Jane Cordell, James J. Fryett, Kazuko Ueno, Rebecca Darlay, Yoshihiro Aiba, Yuki Hitomi, Minae Kawashima, Nao Nishida	2021	110
12	Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network PLoS ONE ·Loreta Anesti Kondili, Giovanni Battista Gaeta, Maurizia Rossana Brunetto, Alfredo Di Leo, Andrea Iannone, Teresa Antonia Santantonio, Adele Giammario, Giovanni Raimondo	2017	106
13	Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories Journal of Hepatology ·Devin Razavi‐Shearer, Hannah Child, K. Razavi-Shearer, Alexis S. Voeller, Homie A. Razavi, Maria Buti Ferret, Frank Tacke, Norah A. Terrault	2023	60
14	A “systems medicine” approach to the study of non-alcoholic fatty liver disease Digestive and Liver Disease ·Salvatore Petta, Luca V. C. Valenti, Elisabetta Bugianesi, Giovanni Targher, Stefano Bellentani, Ferruccio Bonino, Ele Ferrannini, Amedeo Lonardo	2015	57
15	Long‐term outcome of inactive and active, low viraemic HB eAg‐negative‐hepatitis B virus infection: Benign course towards HB sAg clearance Liver International ·Filippo Oliveri, Lidia Surace, Daniela Cavallone, Piero Colombatto, Gabriele Ricco, Nicola Salvati, Barbara Coco, Veronica Romagnoli	2017	56
16	Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals Digestive and Liver Disease ·Ana Lleò, Andrea Aglitti, Alessio Aghemo, Patrick Maisonneuve, Savino Bruno, Marcello Persico, Maria Grazia Rendina, Alessia Ciancio	2018	55
17	Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease PLoS ONE ·Quan Yuan, Liuwei Song, Daniela Cavallone, Francesco Moriconi, Beatrice Cherubini, Piero Colombatto, Filippo Oliveri, Barbara Coco	2015	54
18	Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study European Journal of Endocrinology ·Eleonora Sisti, Barbara Coco, Francesca Menconi, Marenza Leo, Roberto Rocchi, Francesco Latrofa, Maria Antonietta Profilo, Barbara Mazzi	2015	49
19	Pathway-based analysis of primary biliary cirrhosis genome-wide association studies Genes and Immunity ·Siddhartha Kar, Michael F. Seldin, W. Chen, E. Lu, Gideon Morris Hirschfield, Pietro Invernizzi, Jenny Heathcote, Daniele Cusi	2013	42
20	X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis Gastroenterology ·Rosanna Asselta, Elvezia Maria Paraboschi, Alessio Gerussi, Heather Jane Cordell, George F. Mells, Richard N. Sandford, David E. Jones, Minoru Nakamura	2021	41

About Barbara Coco

Barbara Coco is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Rheumatology and Pathology and Forensic Medicine, having authored 99 papers that have together received 4.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (50 papers), Hepatitis B Virus Studies (40 papers), Liver Disease Diagnosis and Treatment (35 papers), Liver Diseases and Immunity (15 papers), Systemic Lupus Erythematosus Research (5 papers), Hepatitis Viruses Studies and Epidemiology (4 papers), Ophthalmology and Eye Disorders (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Hepatology (2.4k citations), Epidemiology (2.6k citations), Immunology (175 citations), Surgery (344 citations) and Pathology and Forensic Medicine (135 citations). Barbara Coco has collaborated with scholars based in Italy, United States and China. Frequent co-authors include Maurizia Rossana Brunetto, Ferruccio Bonino, Filippo Oliveri, Piero Colombatto, Pietro Ciccorossi, Rodolfo Sacco, A.M. Maina, Veronica Romagnoli, Beatrice Cherubini and Daniela Cavallone. Their work appears in journals such as Digestive and Liver Disease, Journal of Hepatology, Gastroenterology, Alimentary Pharmacology & Therapeutics and Liver International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Barbara Coco

Impact in

Papers in i

In The Last Decade

Barbara Coco

Barbara Coco's Hit Papers

Peers

Countries citing papers authored by Barbara Coco

Fields of papers citing papers by Barbara Coco

All Works

About Barbara Coco

Explore authors with similar magnitude of impact

Papers in